BackgroundThe modified Illinois change of direction test (MICODT) is an asymmetrical test because the numbers of changes of direction performed to the right and to the left are unequal. Therefore, it is possible that the asymmetry of this test may influence agility performance testing.ObjectivesThe aim of this study was to compare two opposite/mirrored versions of the modified Illinois change of direction test.Patients and MethodsForty-six right-footed soccer players (17.2 ± 1.6 years-old) participated in the study. Players performed a modified Illinois change of direction test and a mirrored version of this test “inverted modified Illinois change of direction test” (I/MICODT) in a randomized and counter-balanced order. Paired t-test was used to determine whether significant differences existed between time performances of the tests as a within-subjects measure. Players were thereafter stratified into MICODT group or I/MICODT group according to their best performance and independent t-tests were used to determine differences between groups.ResultsThe analysis revealed no significant difference in time performance between the two versions of test as a within-subjects measure (P > 0.05, ES = 0.05). However, significant better time performances among inverted modified Illinois change of direction group (52% of players) were found when compared to the modified Illinois change of direction group (48% of players) (P < 0.04, ES = 0.66).ConclusionsThe modified Illinois change of direction test must be considered as an asymmetrical test because it underestimates more than half of the players’ agility performances. Therefore, fitness coaches should take these results into account when using this test.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.